-
EP2815762
European procedure
Extract from the Register of European Patents
EP About this file: EP2815762
| EP2815762 - CONJUGATION PROCESS OF BACTERIAL POLYSACCHARIDES TO CARRIER PROTEINS [Right-click to bookmark this link] | |||
| Former [2014/52] | Conjugation process of bacterial polysaccharides to carrier proteins | ||
| [2015/13] | Status | The patent has been granted Status updated on 28.04.2017 Database last updated on 26.04.2025 | |
| Former | Grant of patent is intended Status updated on 16.02.2017 | Most recent event Tooltip | 17.07.2020 | Lapse of the patent in a contracting state New state(s): AL | published on 19.08.2020 [2020/34] | Applicant(s) | For all designated states GlaxoSmithKline Biologicals S.A. Rue de l'Institut, 89 1330 Rixensart / BE | [2017/22] |
| Former [2014/52] | For all designated states GlaxoSmithKline Biologicals S.A. rue de l'Institut, 89 1330 Rixensart / BE | Inventor(s) | 01 /
Biemans, Ralph Leon GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89 B-1330 Rixensart / BE | 02 /
Duvivier, Pierre GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89 B-1330 Rixensart / BE | 03 /
Gavard, Olivier Francis Nicolas GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89 B-1330 Rixensart / BE | [2014/52] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [N/P] |
| Former [2014/52] | Baker, Suzanne J. GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | Application number, filing date | 14181075.4 | 07.03.2011 | [2014/52] | Priority number, date | GB20100003922 | 09.03.2010 Original published format: GB 201003922 | [2014/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2815762 | Date: | 24.12.2014 | Language: | EN | [2014/52] | Type: | A3 Search report | No.: | EP2815762 | Date: | 25.03.2015 | Language: | EN | [2015/13] | Type: | B1 Patent specification | No.: | EP2815762 | Date: | 31.05.2017 | Language: | EN | [2017/22] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 24.02.2015 | Classification | IPC: | A61K39/02 | [2014/52] | CPC: |
A61K47/61 (EP,US);
A61K39/02 (KR);
A61K31/70 (KR);
A61K39/092 (EP,US);
A61K47/50 (KR);
A61K47/6415 (EP,US);
A61K47/646 (EP,US);
A61P31/04 (EP);
A61P31/16 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/52] | Extension states | BA | 14.08.2014 | ME | 14.08.2014 | Title | German: | Konjugationsverfahren für bakterielle Polysaccharide an Trägerproteine | [2017/10] | English: | CONJUGATION PROCESS OF BACTERIAL POLYSACCHARIDES TO CARRIER PROTEINS | [2015/13] | French: | Procédé de conjugaison de polysaccharides bactériens à protéines porteuses | [2017/10] |
| Former [2014/52] | Konjugationsverfahren für bakterielle Polysaccharide an Trägerproteine | ||
| Former [2014/52] | Conjugation process of bacterial polysaccharides to carrier proteins | ||
| Former [2014/52] | Procédé de conjugaison de polysaccharides bactériens à protéines porteuses | Examination procedure | 14.08.2014 | Examination requested [2014/52] | 25.09.2015 | Amendment by applicant (claims and/or description) | 20.01.2016 | Communication of intention to grant the patent | 17.05.2016 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 16.06.2016 | Despatch of a communication from the examining division (Time limit: M02) | 27.07.2016 | Reply to a communication from the examining division | 17.02.2017 | Communication of intention to grant the patent | 20.04.2017 | Fee for grant paid | 20.04.2017 | Fee for publishing/printing paid | 20.04.2017 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP11709065.4 / EP2544708 | Opposition(s) | Opponent(s) | 01
26.02.2018
24.05.2019
WITHDRAWN Merck Sharp & Dohme Corp. One Merck Drive Whitehouse Station, NJ 08889 / US Opponent's representative Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | 02
28.02.2018
19.11.2019
WITHDRAWN Sanofi Pasteur Inc./Sanofi-Aventis Deutschland GmbH/Sanofi Winthrop Industries S.A. 1 Discovery Drive/Brüningstr. 50/ 20 Avenue Raymond Aron Swiftwater PA 18370/65926 Frankfurt am Main/ 92160 Antony / US Opponent's representative Zwicker, Jörk, et al, et al ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE | 03
28.02.2018
19.11.2019
WITHDRAWN SK Chemicals Co., Ltd. 310, Pangyo-ro, Budang-gu Seongnam-si, Gyeonggi-do 13494 / KR Opponent's representative Zwicker, Jörk, et al, et al ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE | [2019/52] |
| Former [2019/27] | |||
| Opponent(s) | 01
26.02.2018
24.05.2019
WITHDRAWN Merck Sharp & Dohme Corp. One Merck Drive Whitehouse Station, NJ 08889 / US Opponent's representative Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | ||
| 02
28.02.2018
13.03.2018
ADMISSIBLE Sanofi Pasteur Inc./Sanofi-Aventis Deutschland GmbH/Sanofi Winthrop Industries S.A. 1 Discovery Drive/Brüningstr. 50/ 20 Avenue Raymond Aron Swiftwater PA 18370/65926 Frankfurt am Main/ 92160 Antony / US Opponent's representative Zwicker, Jörk, et al, et al ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE | |||
| 03
28.02.2018
13.03.2018
ADMISSIBLE SK Chemicals Co., Ltd. 310, Pangyo-ro, Budang-gu Seongnam-si, Gyeonggi-do 13494 / KR Opponent's representative Zwicker, Jörk, et al, et al ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE | |||
| Former [2018/15] | |||
| Opponent(s) | 01
26.02.2018
01.03.2018
ADMISSIBLE Merck Sharp & Dohme Corp. One Merck Drive Whitehouse Station, NJ 08889 / US Opponent's representative Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | ||
| 02
28.02.2018
WITHDRAWN Sanofi Pasteur Inc./Sanofi-Aventis Deutschland GmbH/Sanofi Winthrop Industries S.A. 1 Discovery Drive/Brüningstr. 50/ 20 Avenue Raymond Aron Swiftwater PA 18370/65926 Frankfurt am Main/ 92160 Antony / US Opponent's representative Zwicker, Jörk, et al, et al ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE | |||
| 03
28.02.2018
WITHDRAWN SK Chemicals Co., Ltd. 310, Pangyo-ro, Budang-gu Seongnam-si, Gyeonggi-do 13494 / KR Opponent's representative Zwicker, Jörk, et al, et al ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE | |||
| Former [2018/14] | |||
| Opponent(s) | 01
26.02.2018
01.03.2018
ADMISSIBLE Merck Sharp & Dohme Corp. One Merck Drive Whitehouse Station, NJ 08889 / US Opponent's representative Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | 16.03.2018 | Invitation to proprietor to file observations on the notice of opposition | 25.09.2018 | Reply of patent proprietor to notice(s) of opposition | 19.11.2019 | Cancellation of oral proceeding that was planned for 20.11.2019 | 20.11.2019 | Date of oral proceedings | 26.11.2019 | Despatch of communication that the opposition procedure will be closed | 06.12.2019 | Legal effect of closure of opposition procedure [2020/16] | Fees paid | Renewal fee | 14.08.2014 | Renewal fee patent year 03 | 14.08.2014 | Renewal fee patent year 04 | 06.03.2015 | Renewal fee patent year 05 | 08.03.2016 | Renewal fee patent year 06 | 07.03.2017 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 31.05.2017 | MC | 31.05.2017 | MK | 31.05.2017 | RS | 31.05.2017 | SM | 31.05.2017 | [2020/34] |
| Former [2020/31] | MC | 31.05.2017 | |
| MK | 31.05.2017 | ||
| RS | 31.05.2017 | ||
| SM | 31.05.2017 | ||
| Former [2018/52] | MC | 31.05.2017 | |
| RS | 31.05.2017 | ||
| SM | 31.05.2017 | ||
| Former [2018/13] | RS | 31.05.2017 | |
| SM | 31.05.2017 | ||
| Former [2017/52] | RS | 31.05.2017 | Documents cited: | Search | [Y]US4356170 (JENNINGS HAROLD J, et al) [Y] 1-3,9-12 * column 3, paragraph 3 *; | [Y]WO2006082530 (CHIRON SRL [IT], et al) [Y] 1-3,9-12 * pages 2,7-11; figures 1,2,6-8; claims 1,2,18-26 *; | [Y]WO2007000322 (GLAXOSMITHKLINE BIOLOG SA [BE], et al) [Y] 1-3,9-12 * pages 3,14; claims 9,26-33,41-53 *; | [Y]WO2007071707 (GLAXOSMITHKLINE BIOLOG SA [BE], et al) [Y] 9-11* page 18 - page 23; examples 6-14; claims 22,89,93,94,134,136 *; | [Y]US2007184071 (HAUSDORFF WILLIAM P [BE], et al) [Y] 1-3,9-12 * paragraph [0196] - paragraph [0232] * * paragraph [0003] - paragraph [0008] * * paragraph [0246] *; | [Y] - ANDERSON ET AL, "Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant.", THE JOURNAL OF IMMUNOLOGY, (19860801), vol. 137, no. 4, ISSN 0022-1767, pages 1181 - 1186, XP055007229 [Y] 1-3,9-12 * the whole document * | [Y] - KIM J S ET AL, "Monitoring activation sites on polysaccharides by GC-MS", ANALYTICAL BIOCHEMISTRY, ACADEMIC PRESS INC, NEW YORK, vol. 358, no. 1, doi:10.1016/J.AB.2006.08.016, ISSN 0003-2697, (20061101), pages 136 - 142, (20061101), XP024942320 [Y] 1-3,9-12 * the whole document * DOI: http://dx.doi.org/10.1016/j.ab.2006.08.016 | [Y] - STEINHOFF M C ET AL, "A RANDOMIZED COMPARISON OF THREE BIVALENT STREPTOCOCCUS PNEUMONIAE GLYCOPROTEIN CONJUGATE VACCINES IN YOUNG CHILDREN: EFFECT OF POLYSACCHARIDE SIZE AND LINKAGE CHARACTERISTICS", THE PEDIATRIC INFECTIOUS DISEASE JOURNAL, LIPPINCOTT WILLIAMS & WILKINS, US, (19940501), vol. 13, no. 5, doi:10.1097/00006454-199405000-00007, ISSN 0891-3668, pages 368 - 372, XP000600692 [Y] 1-3,9-12 * the whole document * DOI: http://dx.doi.org/10.1097/00006454-199405000-00007 | by applicant | US4057685 | US4235877 | US4365170 | US4459286 | EP0161188 | US4596556 | EP0208375 | US4673574 | US4709017 | EP0281673 | US4790824 | US4808700 | EP0372501 | US4940460 | US4941880 | EP0378881 | US4950740 | WO9101146 | EP0427347 | US5064413 | EP0471177 | EP0477508 | EP0497524 | EP0497525 | WO9303761 | WO9315760 | WO9317712 | WO9403208 | WO9405325 | EP0594610 | US5312335 | US5334144 | US5339163 | US5383851 | WO9508348 | US5466220 | US5480381 | US5503627 | US5520639 | WO9629094 | US5569189 | WO9634960 | WO9701638 | US5599302 | WO9713785 | WO9713537 | US5649912 | WO9732980 | WO9737705 | WO9741731 | WO9748440 | US5704911 | WO9818930 | WO9820734 | US5766608 | WO9828037 | US5843711 | US5843464 | WO9855606 | WO9858668 | US5893397 | WO9927961 | US5917017 | WO9934850 | US5993412 | WO9964067 | WO0010599 | WO0037105 | WO0056360 | WO0061761 | WO0113977 | EP1092444 | WO0172337 | WO0209746 | US6455673 | WO02091998 | WO2006067632 | US2007184072 | - CHU C. ET AL., INFECT. IMMUNITY, (1983), page 245 256 | - SHOUSUN CHEN SZU ET AL., CARBOHYDRATE RESEARCH, (1986), vol. 152, pages 7 - 20 | - UCHIDA ET AL., J. BIOL. CHEM., (1973), vol. 218, pages 3838 - 3844 | - KUO ET AL., INFECT IMMUN, (1995), vol. 63, pages 2706 - 13 | - FALUGI ET AL., EUR J IMMUNOL, (2001), vol. 31, pages 3816 - 3824 | - BARALDOI ET AL., INFECT IMMUN, (2004), vol. 72, pages 4884 - 7 | - GEVER ET AL., MED. MICROBIOL. IMMUNOL., (1979), vol. 165, pages 171 - 288 | - TETRAHEDRON LETTERS, (200506), vol. 46, pages 4479 - 4482 | - HELMINEN ME ET AL., INFECT. IMMUN., (1993), vol. 61, pages 2003 - 2010 | Opposition | US4902506 | US5565204 | US5623057 | WO9831393 | WO0222168 | WO2004043376 | WO2005014037 | US2007184071 | US2007184072 | WO2009000825 | US4356170 | WO9405325 | WO9605859 | US2004213803 | EP1625850 | WO2006082530 | WO2007000322 | US2007141084 | WO2007071707 | WO2008157590 | EP2815762 | - ANDERSON et al., "Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant", The Journal of Immunology, (19860815), vol. 137, no. 4, pages 1181 - 1186, XP055007229 | - "Creating Specific Functionalities", HERMANSON, Bioconjugate Techniques, (20080000), pages 129 - 131, XP055467625 | - KIM et al., "Monitoring activation sites on polysaccharides by GC-MS", Analytical Biochemistry, (20060830), vol. 358, pages 136 - 142, XP005694532 DOI: http://dx.doi.org/10.1016/j.ab.2006.08.016 | - "product information", Excerpt of 'PDR, (19900207), pages 880-881 - ,1431-1432, XP055467629 | - FRASCH, "Preparation of bacterial polysaccharide-protein conjugates: Analytical and manufacturing challenges", Vaccine, (20090624), vol. 27, no. 46, pages 6468 - 6470, XP026704485 DOI: http://dx.doi.org/10.1016/j.vaccine.2009.06.013 | - "chapter 11 conjugation chemistry", LEES et al., Pneumococcal Vaccines: the Impact of Conjugate Vaccine, (20080000), pages 163 - 174, XP055467636 | - KUO et al., "Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccines", Infect Immun, (19950000), vol. 63, pages 2706 - 2713, XP055033057 | - "Sigma catalogue", Biochemicals and Reagents, For Life Science Research, (20000000), page 781, XP055467643 | - "product information", PDR 63, (20081118), pages 3241 - 3247, XP055467646 | - LEE, "Quality Control of Polyvalent Pneumococcal Polysaccharide-Protein Conjugate Vaccine by Nephelometry", The International Association for Biologicals, (20020000), vol. 63, pages 97 - 103, XP002330498 DOI: http://dx.doi.org/10.1006/biol.2001.0320 | - ANDERSON et al., "Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant", J. of Immunol., (19860815), vol. 137, no. 4, pages 1181 - 1186, XP055007229 | - KIM J.S., "Monitoring activation sites on polysaccharides by GC-MS", Analytical Biochemistry, New York, (20060830), vol. 358, no. 1, pages 136 - 142, XP005694532 DOI: http://dx.doi.org/10.1016/j.ab.2006.08.016 | - STEINHOFF, M.C. et al., "A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children: effect of polysaccharide size and linkage characteristics", Pediatric Inf. Disease J., (19940501), vol. 13, no. 5, pages 368 - 372, XP000600692 DOI: http://dx.doi.org/10.1097/00006454-199405000-00007 | - PEETERS, CC et al., "Preparation of polysaccharide-conjugate vaccines", PEETERS, CC et al., Robinson A., Hudson M.J., Cranage M.P., Vaccine Protocols. Methods in Molecular Medicine?, Humana Press, (20030201), vol. 87, pages 153 - 173, ISBN 978-1-58829-140-0, XP002310929 DOI: http://dx.doi.org/10.1385/1-59259-399-2:153 | - FRASCH C.E, "Preparation of bacterial polysaccharide-protein conjugates: Analytical and manufacturing challenges", Vaccine, (20091030), vol. 27, no. 46, pages 6468 - 6470, XP026704485 DOI: http://dx.doi.org/10.1016/j.vaccine.2009.06.013 | - LAFERRIERE, C.A. et al., "The synthesis of Streptococcus pneumoniae polysaccharide-tetanus toxoid conjugates and the effect of chain length on immunogenicity", Vaccine, (19971102), vol. 15, no. 2, pages 179 - 186, XP002301344 DOI: http://dx.doi.org/10.1016/S0264-410X(96)00148-X | - LEE, C.J., "Quality control of polyvalent pneumococcal polysaccharide-protein conjugate vaccine by nephelometry", Biologicals, (20020600), vol. 30, no. 2, pages 97 - 103, XP002330498 DOI: http://dx.doi.org/10.1006/biol.2001.0320 | - RICHARDS, J.C. et al., "Structure of the specific capsular polysaccharide of Streptococcus pneumoniae type 23F (American type 23)", Biochem Cell Biol, (19880700), vol. 66, pages 758 - 771, XP009155178 DOI: http://dx.doi.org/10.1139/o88-087 | - ANDERSON, P.W. et al., "Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen unterminally coupled to the diphtheria protein CRM197.", J Immunol, (19890401), vol. 142, no. 7, pages 2464 - 2468, XP002913714 | - "1. Functional Targets", HERMANSON, G.T., Bioconjugate Techniques, Academic Press, Inc, pages 114 - 116, XP055470232 | - KIM J.S., "Monitoring activation sites on polysaccharides by GC-MS", Analytical Biochemistry, New York, (20060830), vol. 358, no. 1, pages 136 - 142, XP024942320 DOI: http://dx.doi.org/10.1016/j.ab.2006.08.016 | - PEETERS, CC et al., "Preparation of polysaccharide-conjugate vaccines", Methods in Molecular Medicine?, (20030200), vol. 87, pages 153 - 173, XP002310929 DOI: http://dx.doi.org/10.1385/1-59259-399-2:153 | - FRASCH C.E, "Preparation of bacterial polysaccharide-protein conjugates: Analytical and manufacturing challenges", Vaccine, (20090624), vol. 27, no. 46, pages 6468 - 6470, XP026704485 DOI: http://dx.doi.org/10.1016/j.vaccine.2009.06.013 | - LEE, C.J., "Quality control of polyvalent pneumococcal polysaccharide-protein conjugate vaccine by nephelometry", Biologicals, (20020600), vol. 30, pages 97 - 103, XP002330498 DOI: http://dx.doi.org/10.1006/biol.2001.0320 | - RICHARDS, J.C. et al., "Structure of the specific capsular polysaccharide of Streptococcus pneumoniae type 23F (American type 23)", Biochem Cell Biol, (19880700), vol. 66, no. 7, pages 758 - 771, XP009155178 DOI: http://dx.doi.org/10.1139/o88-087 | - ANDERSON, P.W. et al., "Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen unterminally coupled to the diphtheria protein CRM197.", J Immunol, (19890407), vol. 142, pages 2464 - 2468, XP002913714 | - "1. Functional Targets", HERMANSON, G.T., Bioconjugate Techniques, Academic Press, Inc, (19960108), pages 114 - 116, XP055470232 | - Anonymous, "The Effect of Temperature on Rate of Reaction", LibreTexts Chemistry, pages 1 - 2, URL: https://chem.libretexts.org/Bookshelves/Physical_and_Theoretical_Chemistry_Textbook_Maps/Supplemental_Modules_(Physical_and_Theoretical_Chemistry)/Kinetics/Rate_Laws/Reaction_Mechanisms/Reaction_Mechanisms/The_Effect_of_Temperature_on_Rate_of_Reaction, XP055642431 | - KRISTIANSEN et al., "Periodate oxidation of polysaccharides for modification of chemical and physical properties", Carbohydrate Res., (20100000), vol. 345, no. 10, pages 1264 - 1271, XP027118778 | - Anonymous, "Room temperature", Wikipedia, (20190810), pages 1 - 3, URL: https://en.wikipedia.ortz/wiki/Room_ temperature, XP055642435 | - Anonymous, "Biological Buffers", AppliChem, (20080000), pages 1 - 20, XP055591620 |